ROTHMAN ORTHOPAEDIC SPECIALTY HOSPIT — History
CCN 390322 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$65M
Latest Revenue (FY2022)
+5.5%
Revenue CAGR (3yr)
20.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $58M | $63M | $65M | +3.6% | +5.5% |
| Operating Expenses | $47M | $50M | $51M | +3.3% | +5.1% |
| Operating Margin | 20.0% | 20.4% | 20.6% | +0.9% | +1.3% |
| Net Income | $12M | $13M | $13M | +4.5% | +6.9% |
| Licensed Beds | 24 | 24 | 24 | +0.0% | +0.0% |
| Total Patient Days | 2,746 | 2,615 | 1,350 | -48.4% | -29.9% |
| Medicare Day % | 35% | 38% | 36% | -6.9% | +0.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +11.3% ($58M → $65M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.5%
This Hospital
+7.6%
State Avg
Latest Margin
20.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $68M | 20.9% |
| FY2024 (proj) | $71M | 21.1% |
| FY2025 (proj) | $75M | 21.4% |